olorinab: Clinical Trials

2 trials of olorinab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow olorinab: new trials by email Literature Review of olorinab trials Research Report on olorinab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
Olorinab, Placebo - Irritable Bowel Syndrome
Phase 2TerminatedArena Pharmaceuticals2732019-07-242025-01-30
Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain
Olorinab - Crohn's Disease, Abdominal Pain
Phase 2CompletedArena Pharmaceuticals142017-07-192021-11-02

Conditions studied

Abdominal Pain (2)  ·  Crohn Disease (1)  ·  Irritable Bowel Syndrome (1)

Sponsors

Arena Pharmaceuticals (2)

Countries

United States (2)

Top investigators

Arena CT.gov Administrator (2)

Results publications

PMID 33863856, PMID 36740814